Life Sciences Early Phase Patient Trials

The biopharmaceutical industry has a growing need for early phase clinical studies in patients to support more advanced and informed go/no-go decisions, ultimately enabling more efficient and productive future development planning.

To meet this industry requirement of complex early phase patient clinical trials, we offer a multisource recruitment approach which includes:

An established network of nephrologists and gastroenterologists to ensure fast recruitment of special population of renal and hepatic impaired patients and the conduct of these complex early phase studies

Collaboration with a network of clinical sites, hospitals and specialists, providing patient referrals

Why choose early phase patient clinical trials from SGS?

Our multi-site hospital partnership model helps you:

Achieve faster site activation through efficient Clinical Trial Agreement negotiations with the investigators

Access large and diverse patient populations for a variety of complex and special indications

Improve the recruitment rate, thanks to the hospital partner commitment

Benefit from dedicated expertise for the growing complexity of study designs

Access guaranteed data quality due to our own staff and SOPs used in each site

World-class early phase patient clinical trials

Our units are managed by a dedicated team, working in a standardized way. Our team collaborates with the treating hospital physicians, who can either act as a principle investigator or sub-investigator. In both cases, our site staff will keep the oversight ensuring the protocol is conducted as per our quality and safety standards.

Our satellite and partner network offers you the best drug development solutions and clinical trial services in several therapeutic areas, including:

Infectious diseases

Respiratory

CNS

Cardiology

Metabolic disorders

Oncology

Dermatology

Organ impairment

ImmunologyGeriatrics

Nephrology

Vascular surgery

Contact us today to discuss how we can help with your early phase in-patients clinical trial program.